Triad Wealth Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$313K Sell
3,651
-20
-0.5% -$1.96K 0.02% 424
2026
Q2
$387K Buy
3,671
+110
+3% +$9.8K 0.02% 388
2026
Q1
$256K Buy
3,561
+459
+15% +$35.4K 0.02% 425
2025
Q4
$246K Buy
+3,102
New +$245K 0.02% 425
2024
Q3
– Sell
-300
Closed -$17.7K – 237
2024
Q2
$17.7K Buy
+300
New +$18.8K 0.01% 369

Other funds holding CVS

Triad Wealth Partners's CVS Position: Q3 2026 in Review

Triad Wealth Partners reduced its CVS Health (CVS) stake by 0.54% in Q3 2026, selling an estimated $1.96K and leaving 3,651 shares worth $313K. The position accounts for 0.02% of the portfolio, ranked #424.

Triad Wealth Partners first reported a position in CVS in Q2 2024 and has held it in 5 quarters since. The position peaked at $387K in Q2 2026. 1,324 funds tracked by Wall St. Rank hold CVS as of Q3 2026.

  • Triad Wealth Partners held 3,651 shares of CVS Health worth $313K as of Q3 2026.
  • Triad Wealth Partners sold 20 CVS Health shares in Q3 2026, an estimated $1.96K.
  • CVS Health made up 0.02% of Triad Wealth Partners's portfolio in Q3 2026, its #424 holding.
  • Triad Wealth Partners first reported a position in CVS Health in Q2 2024 and has held it in 5 quarters since.
  • Triad Wealth Partners's CVS Health position peaked at $387K in Q2 2026.
  • 1,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.

Based on Triad Wealth Partners's 13F filing for Q3 2026, filed 26 Oct 2026.